Results 231 to 240 of about 45,720 (293)

Discovery and biological profile of pyridachlometyl

Pest Management Science, Volume 81, Issue 5, Page 2442-2449, May 2025.
Binding sites of pyridachlometyl and benzimidazole fungicide (carbendazim). Abstract Pyridachlometyl is a novel tubulin dynamics modulator fungicide developed by Sumitomo as a new agent designed to tackle fungicide resistance. Pyridachlometyl is being developed as a first‐in‐class molecule with an anti‐tubulin mode of action, the chemical structure of ...
Yuichi Matsuzaki, Makoto Kurahashi, Satoshi Watanabe, So Kiguchi, Toshiyuki Harada, Fukumatsu Iwahashi   +5 more
wiley   +1 more source

Anxiolytic Efficacy of Indirubin: In Vivo Approach Along with Receptor Binding Profiling and Molecular Interaction with GABAergic Pathways. [PDF]

ChemistryOpen
Disha IJ, Hasan R, Bhuia S, Ansari SA, Ansari IA, Islam MT.   +5 more
europepmc   +1 more source

Acute Treatment of 60‐Hz Electric Field Increases Parasympathetic Activity in Depressed Subjects: A Pilot Study Using Heart Rate Variability Analysis

IEEJ Transactions on Electrical and Electronic Engineering, Volume 20, Issue 5, Page 749-753, May 2025.
Research indicated that extremely low‐frequency (ELF) electric field (EF) treatment modifies autonomic activity in healthy subjects; however, the effects do not persist after the treatment. This study examined whether persistence of the effects is dependent on the baseline autonomic conditions.
Toshikazu Shinba, Takaki Nedachi, Shinji Harakawa   +2 more
wiley   +1 more source

Anxyiolytic activity of fortified Centella asciatica

Bangladesh Journal of Pharmacology, 2015
Issac Paul, Ravi Mundugaru, Narayana Prakash, Ravishankar Basavaiah   +3 more
doaj  

Anxiolytic Effect of Jasmine Aromatherapy in Pediatric Dental Procedures: A Single-Blinded Randomized Placebo-Controlled Trial. [PDF]

Front Dent
Jafarzadeh Samani M, Ziaei S, Monjezi N, Fazaeli R, Sedaghat N, Panahi H, Mortazavi S.   +6 more
europepmc   +1 more source

Recovery and Recurrence From Major Depression in Adolescence and Adulthood

Acta Psychiatrica Scandinavica, Volume 151, Issue 5, Page 625-633, May 2025.
ABSTRACT Objective The study aimed to estimate 5‐year recurrence rates of first‐episode major depressive disorder (MDD) and assess the impact of adolescence on recurrence likelihood after the first episode, compared to adults. Methods A pre‐registered retrospective cohort study that utilized epidemiological data from the Stockholm MDD Cohort (1997–2018)
Adrian E. Desai Boström, Thomas Cars, Clara Hellner, Johan Lundberg   +3 more
wiley   +1 more source

Association of anxiolytic drugs with Torsade de Pointes: a pharmacovigilance study of the Food and Drug Administration Adverse Event Reporting System. [PDF]

J Pharm Policy Pract
Ali Z, Ismail M, Rehman IU, Goh KW, Razi P, Ming LC.   +5 more
europepmc   +1 more source

Medication equivalent dose program in R

Psychiatry and Clinical Neurosciences, EarlyView.
Shinsuke Koike, Yoji Hirano, Shinichiro Nakajima, Kentaro Morita   +3 more
wiley   +1 more source

Efficacy of cannabidiol alone or in combination with Δ‐9‐tetrahydrocannabinol for the management of substance use disorders: An umbrella review of the evidence

Addiction, Volume 120, Issue 5, Page 813-834, May 2025.
Abstract Background and Aims Substance use disorders (SUD) lead to a high burden of disease, yet treatment options are limited. Cannabidiol (CBD) is being investigated as a potential therapeutic target due to its pharmacological properties and mode of action in the endocannabinoid system.
Bertrand Redonnet, Filiz Eren, Guillaume Avenin, Maria Melchior, Murielle Mary‐Krause   +4 more
wiley   +1 more source